Cliical Trials: Retention Plans & Visit Flexibility

Governance, Policies and SOPs to Operationalize Retention Plans & Visit Flexibility In today’s ever-evolving landscape of medidata clinical trials, the importance of patient retention and the flexibility of visits cannot be overstated. Effective governance, robust policy frameworks, and clearly defined Standard Operating Procedures (SOPs) play crucial roles in operationalizing retention plans. This article provides a…

Read More “Governance, Policies and SOPs to Operationalize Retention Plans & Visit Flexibility” »

Digital Tools, Analytics and Targeting to Strengthen Retention Plans & Visit Flexibility Retention remains one of the most critical components in the success of clinical trials. With the changing landscape of decentralized clinical trials (DCTs), there is a growing necessity for sponsors to adopt digital tools, leverage analytics, and implement targeted strategies to enhance patient…

Read More “Digital Tools, Analytics and Targeting to Strengthen Retention Plans & Visit Flexibility” »

Future Trends: Digital, Patient-Centric and Data-Driven Retention Plans & Visit Flexibility Future Trends: Digital, Patient-Centric and Data-Driven Retention Plans & Visit Flexibility As clinical trials evolve to meet the demands of a more digital and patient-centered landscape, it becomes crucial to adopt innovative retention plans and flexible visit strategies. Understanding and implementing CAPA in clinical…

Read More “Future Trends: Digital, Patient-Centric and Data-Driven Retention Plans & Visit Flexibility” »

Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK In the evolving landscape of clinical research, the retention of participants is critical for the success of clinical trials. Regulatory authorities such as the FDA, EMA, and MHRA emphasize…

Read More “Global Considerations for Retention Plans & Visit Flexibility Across US, EU and UK” »

Budgeting, Contracts and FMV Considerations for Retention Plans & Visit Flexibility In the burgeoning landscape of clinical trials, the convergence of budget management, contractual obligations, and fair market value (FMV) considerations plays a vital role in ensuring patient retention and visit flexibility. This comprehensive guide aims to equip clinical operations, regulatory affairs, and medical affairs…

Read More “Budgeting, Contracts and FMV Considerations for Retention Plans & Visit Flexibility” »

Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well Introduction to Retention Strategies in Clinical Trials Retention in clinical trials is critical to ensure that the collected data is of high quality, comprehensive, and reliable. Engaging with participants…

Read More “Training Study Teams and Vendors to Execute Retention Plans & Visit Flexibility Well” »

Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility In the evolving landscape of oncology clinical research, patient retention remains a critical factor influencing the success of clinical trials. As demands for diverse patient populations surge, clinical trial professionals must…

Read More “Partnering with Sites and Communities to Scale Retention Plans & Visit Flexibility” »